?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
The Issue
Our Solutions
Biosimilars 101
Foundations
Core Principles
FDA Regulatory Tenets
Biosimilars FAQs
Future Evolution of Biosimilar Development
Approved Biosimilars
Advocacy
Our Action
Tools
News
Resources
Get Involved
Partners
News
Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
August 6, 2022
signalgroup
Biosimilars Forum Warns Limited Negotiation Policies Will Stymie Innovation
News
July 28, 2022
signalgroup
Hillel Cohen Member Spotlight
News
July 21, 2022
signalgroup
The Biosimilars Forum Launches Updated Website Content
News
July 14, 2022
signalgroup
Rebecca Mandell Member Spotlight
News
June 22, 2022
signalgroup
The Biosimilars Forum Welcomes Legislation to Hold PBMs Accountable for Unfair Practices
News
June 21, 2022
signalgroup
Rachel Turow Member Spotlight
News
June 16, 2022
signalgroup
Brian Lehman Member Spotlight
News
June 7, 2022
signalgroup
The Biosimilars Forum Commends FTC for Probe into PBMs
News
June 6, 2022
signalgroup
Biosimilars Forum Welcomes Fresenius Kabi
News
April 6, 2022
signalgroup
Biosimilars Forum Letter to Senate HELP Committee on FDA User Fee Agreements
Prev page
03
04
05
06
07
Next page